A PhD position is available for a joint project of the Center of Physiology and Pharmacology (Prof. Dr. med. Michael Fischer) and the Center for Biomedical Research (Dr. Attila Kiss), Medical University of Vienna, Austria. The candidate will use in vitro and in vivo approaches to investigate mechanisms of ischemia-reperfusion injury and will be enrolled in the structured PhD program ‘Molecular Signal Transduction’ or ‘Vascular Biology’.
The candidate is required to have a Diploma or a Masters degree in medicine, biochemistry, biology, pharmacy or a related subject and should have a strong interest in cardiac physiology, neurophysiology, molecular biology and pharmacology. The methods include ex vivo and in vivo models of myocardial ischemia/reperfusion injury, knockout mouse models, primary cell culture, human iPSC- derived cardiomyocytes, vascular reactivity in isolated aorta and coronary artery rings, time-lapse fluorescent microscopy, electrophysiology, as well as standard molecular biology, cell culture, biochemistry and histology. Previous experience with one or more of the listed methods as well as a Felasa B certificate will be considered as advantage. Proficiency in spoken and written English is essential, as well as high accuracy, reliability and good interpersonal skills.
The Medical University of Vienna is with 26 university hospitals, three clinical institutes, 12 theoretical medicine centers and numerous highly specialised laboratories, among the most important cutting-edge research institutes of Europe in the area of biomedicine.
Please apply with a C.V., a brief statement of previous experience and the contact details of two referees until September 5th. The position is funded for three years by the Austrian Science Fund (FWF) and will be available from October 15th 2019.